Manvi Mukherjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Manvi Mukherjee has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Sagar Mandal
Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal
6 shared publications - Neeta Katuwal
Department of Gynecology and Obstetrics, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
4 shared publications - Aastha Malla
Department of Gynecology and Obstetrics, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
3 shared publications - Pooja Paudyal
Department of Gynecology and Obstetrics, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
3 shared publications - Abhishek Kumar Shah
Maharajgunj Medical Campus, Institute of Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
2 shared publications - Kapil Khanal
Department of Gynecology and Obstetrics, Tribhuvan University Teaching Hospital, Kathmandu, Nepal
2 shared publications
Latest Publications
- Open Access
- 10 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6757-6762
46,XX pure gonadal dysgenesis presenting with a massive yolk sac tumor: a diagnostic and surgical challenge – a rare case report
Introduction and importance: Pure gonadal dysgenesis (PGD) is a rare condition that presents as phenotypic female individuals with nonfunctional gonads. The development of malignant germ cell tumors like yolk sac tumors (YSTs) in PGD is exceedingly rare, with a less than 5% risk in 46XX PGD and a 30–40% risk in 46XY PGD. We present a case of YST in a 27-year female with PGD. Case presentation: A 27-year-old woman with primary amenorrhea presented with acute lower abdominal pain and a 20 cm adnexal mass. Hormonal assays showed hypergonadotropic hypogonadism. Alpha-fetoprotein (AFP) exceeded 2000 ng/mL. Magnetic resonance imaging (MRI) demonstrated a large abdominopelvic mass and infantile uterus. Karyotype confirmed 46,XX. The patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by bleomycin, etoposide, and cisplatin (BEP) chemotherapy. Post-treatment AFP levels normalized, and six-month imaging showed no residual disease. Clinical discussion: The genetic basis of PGD is complex, involving numerous genes that result in nonfunctional streak gonads. YSTs are aggressive malignancies typically found in dysgenetic gonads, which are prone to neoplastic transformation, though they are rare presentation. Imaging such as ultrasonography and MRI plays a key role in diagnosing both the extent of gonadal dysgenesis and any associated tumors. Surgical pathway is the cornerstone of treatment with BEP regimen as adjuvant chemotherapy. Conclusion: This rare case highlights the importance of considering YST in PGD patients with abdominal masses and elevated tumor markers and demonstrates that prompt surgical and chemotherapeutic intervention yields favorable outcomes.
- 10 September 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (10) , 6757-6762
Open Access46,XX pure gonadal dysgenesis presenting with a massive yolk sac tumor: a diagnostic and surgical challenge – a rare case report
Introduction and importance: Pure gonadal dysgenesis (PGD) is a rare condition that presents as phenotypic female individuals with nonfunctional gonads. The development of malignant germ cell tumors like yolk sac tumors (YSTs) in PGD is exceedingly rare, with a less than 5% risk in 46XX PGD and a 30–40% risk in 46XY PGD. We present a case of YST in a 27-year female with PGD. Case presentation: A 27-year-old woman with primary amenorrhea presented with acute lower abdominal pain and a 20 cm adnexal mass. Hormonal assays showed hypergonadotropic hypogonadism. Alpha-fetoprotein (AFP) exceeded 2000 ng/mL. Magnetic resonance imaging (MRI) demonstrated a large abdominopelvic mass and infantile uterus. Karyotype confirmed 46,XX. The patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by bleomycin, etoposide, and cisplatin (BEP) chemotherapy. Post-treatment AFP levels normalized, and six-month imaging showed no residual disease. Clinical discussion: The genetic basis of PGD is complex, involving numerous genes that result in nonfunctional streak gonads. YSTs are aggressive malignancies typically found in dysgenetic gonads, which are prone to neoplastic transformation, though they are rare presentation. Imaging such as ultrasonography and MRI plays a key role in diagnosing both the extent of gonadal dysgenesis and any associated tumors. Surgical pathway is the cornerstone of treatment with BEP regimen as adjuvant chemotherapy. Conclusion: This rare case highlights the importance of considering YST in PGD patients with abdominal masses and elevated tumor markers and demonstrates that prompt surgical and chemotherapeutic intervention yields favorable outcomes.
- Open Access
- 21 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2073-2076
Postoperative hormonal modulation in a patient with granulosa cell tumor and myasthenia gravis: a gyneco-oncologic perspective
Introduction and importance: Perioperative management of granulosa cell tumors (GCTs) becomes significantly more complex in patients with neuromuscular conditions such as myasthenia gravis (MG). Herein, we describe a case of surgically managed stage I GCT in a woman with MG and hypothyroidism. This case is unique because the patient developed postoperative cardiac instability attributed to abrupt estrogen withdrawal after oophorectomy, which resolved rapidly with estrogen replacement. Case presentation: A 38-year-old woman (gravida 0, para 0), married for 8 years, and who is a known case of MG and hypothyroidism presented to our center with a 2-week history of dull lower abdominal pain, intensifying during menstruation. The MRI raised a suspicion of malignancy after which the patient was taken for comprehensive staging surgery in which abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. On post-op day 3, she developed palpitations, chest discomfort, progressive fatigue, and drowsiness. The patient was successfully managed with oral estradiol and discharged on post-op day 9. Clinical discussion: From a gynecologic oncologic perspective, comprehensive surgical staging remains the standard of care for apparent early-stage AGCT. In our case, the patient’s co-morbid MG added significant complexity to the perioperative planning. The cardiac arrhythmia developed as a result of sudden withdrawal of estrogen due to oophorectomy was successfully managed with oral estradiol, and the patient was successfully discharged. Conclusion: Prompt recognition of post-oophorectomy hormonal withdrawal and judicious use of estrogen therapy may be essential in mitigating postoperative complications in hormone-sensitive tumors like AGCTs.
- 21 January 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 2073-2076
Open AccessPostoperative hormonal modulation in a patient with granulosa cell tumor and myasthenia gravis: a gyneco-oncologic perspective
Introduction and importance: Perioperative management of granulosa cell tumors (GCTs) becomes significantly more complex in patients with neuromuscular conditions such as myasthenia gravis (MG). Herein, we describe a case of surgically managed stage I GCT in a woman with MG and hypothyroidism. This case is unique because the patient developed postoperative cardiac instability attributed to abrupt estrogen withdrawal after oophorectomy, which resolved rapidly with estrogen replacement. Case presentation: A 38-year-old woman (gravida 0, para 0), married for 8 years, and who is a known case of MG and hypothyroidism presented to our center with a 2-week history of dull lower abdominal pain, intensifying during menstruation. The MRI raised a suspicion of malignancy after which the patient was taken for comprehensive staging surgery in which abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. On post-op day 3, she developed palpitations, chest discomfort, progressive fatigue, and drowsiness. The patient was successfully managed with oral estradiol and discharged on post-op day 9. Clinical discussion: From a gynecologic oncologic perspective, comprehensive surgical staging remains the standard of care for apparent early-stage AGCT. In our case, the patient’s co-morbid MG added significant complexity to the perioperative planning. The cardiac arrhythmia developed as a result of sudden withdrawal of estrogen due to oophorectomy was successfully managed with oral estradiol, and the patient was successfully discharged. Conclusion: Prompt recognition of post-oophorectomy hormonal withdrawal and judicious use of estrogen therapy may be essential in mitigating postoperative complications in hormone-sensitive tumors like AGCTs.
- Open Access
- 15 January 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (2) , 150-153
Intrapartum posterior cul-de-sac rupture, a clinical enigma: a case report
Introduction and importance: Posterior cul-de-sac rupture is a rare intrapartum complication with non-specific symptoms that impede timely diagnosis. Reported risk factors include genital tract anomalies, prior pelvic infection, cesarean scar, and pharmacologic induction (e.g., misoprostol). Case presentation: A 29-year-old primigravida presented at our Obstetrics and Gynecology department with fetal growth restriction at 38 weeks of gestation. Ultrasound revealed fetal growth restriction (an estimated fetal weight of 2196 g, <10th percentile), a single umbilical artery, and normal Doppler findings. Her cervical os was closed, so labor was induced with mifepristone followed by misoprostol. This was followed by spontaneous rupture of membranes. An emergency cesarean section was performed due to fetal distress, revealing a 5-cm tear extending from the pouch of Douglas to the cervicovaginal junction, repaired in layers. Postoperative antibiotics were administered, and she recovered well, with follow-up scheduled after 6 weeks. Clinical discussion: Intrapartum rupture of the posterior cul-de-sac during induced labor is rare. Various circumstances have been associated with posterior vaginal wall ruptures, including vaginal atresia and previous pelvic infections. Despite the absence of identifiable risk factors, induction with misoprostol may have contributed to the rupture. A hallmark symptom is severe abdominal pain, which warrants attention even without known risk factors. Therefore, vigilance is crucial for diagnosing concealed vaginal wall ruptures during labor, particularly in the context of unexplained severe pain. Conclusion: It is crucial to suspect the possibility of a hidden vaginal wall rupture during labor, particularly when there is unexplained acute pain. Future studies should compare outcomes across parity groups and evaluate induction-related risk.
- 15 January 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 138 (2) , 150-153
Open AccessIntrapartum posterior cul-de-sac rupture, a clinical enigma: a case report
Introduction and importance: Posterior cul-de-sac rupture is a rare intrapartum complication with non-specific symptoms that impede timely diagnosis. Reported risk factors include genital tract anomalies, prior pelvic infection, cesarean scar, and pharmacologic induction (e.g., misoprostol). Case presentation: A 29-year-old primigravida presented at our Obstetrics and Gynecology department with fetal growth restriction at 38 weeks of gestation. Ultrasound revealed fetal growth restriction (an estimated fetal weight of 2196 g, <10th percentile), a single umbilical artery, and normal Doppler findings. Her cervical os was closed, so labor was induced with mifepristone followed by misoprostol. This was followed by spontaneous rupture of membranes. An emergency cesarean section was performed due to fetal distress, revealing a 5-cm tear extending from the pouch of Douglas to the cervicovaginal junction, repaired in layers. Postoperative antibiotics were administered, and she recovered well, with follow-up scheduled after 6 weeks. Clinical discussion: Intrapartum rupture of the posterior cul-de-sac during induced labor is rare. Various circumstances have been associated with posterior vaginal wall ruptures, including vaginal atresia and previous pelvic infections. Despite the absence of identifiable risk factors, induction with misoprostol may have contributed to the rupture. A hallmark symptom is severe abdominal pain, which warrants attention even without known risk factors. Therefore, vigilance is crucial for diagnosing concealed vaginal wall ruptures during labor, particularly in the context of unexplained severe pain. Conclusion: It is crucial to suspect the possibility of a hidden vaginal wall rupture during labor, particularly when there is unexplained acute pain. Future studies should compare outcomes across parity groups and evaluate induction-related risk.
- Open Access
- 19 December 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1944-1948
A case report of red degeneration of a uterine fibroid mimicking ovarian malignancy in the postpartum period: a diagnostic challenge
Introduction and importance: Red degeneration of uterine fibroids, though uncommon postpartum, can mimic ovarian malignancies both radiologically and biochemically. This case is unique because the patient had no previously identified fibroid during pregnancy, yet presented in the early postpartum period with an unusually large mass, tumor marker elevation, and imaging features virtually indistinguishable from ovarian dysgerminoma. Case presentation: We report the case of a 37-year-old multiparous woman (G3P3) who presented on the fourth postpartum day with progressive abdominal distension and discomfort. Detailed clinical examination and imaging pointed toward an adnexal mass, likely right ovarian dysgerminoma. Tumor markers, including CA-125 (cancer antigen 125) and β-hCG (beta-human chorionic gonadotropin), were elevated. A staging laparotomy was planned based on the presumptive diagnosis of ovarian malignancy, which revealed a large fundal uterine fibroid undergoing red degeneration. The patient underwent a total abdominal hysterectomy. Clinical discussion: The presence of an adnexal or pelvic mass in the postpartum period presents diagnostic complexity. Red degeneration is a hemorrhagic infarction of a uterine fibroid. The definite diagnosis is often confirmed by laparotomy and histologic confirmation. Tumor markers may be falsely elevated in postpartum women or in association with benign gynecological conditions. Red degeneration should be part of the differential diagnosis when a postpartum woman presents with an abdominopelvic mass, especially if she has a known fibroid. Conclusion: This case underscores the importance of integrating clinical, biochemical, and radiologic data in the diagnosis of uterine fibroids – while remaining open to alternate benign diagnoses at the same time – to avoid overtreatment or delayed appropriate management.
- 19 December 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (2) , 1944-1948
Open AccessA case report of red degeneration of a uterine fibroid mimicking ovarian malignancy in the postpartum period: a diagnostic challenge
Introduction and importance: Red degeneration of uterine fibroids, though uncommon postpartum, can mimic ovarian malignancies both radiologically and biochemically. This case is unique because the patient had no previously identified fibroid during pregnancy, yet presented in the early postpartum period with an unusually large mass, tumor marker elevation, and imaging features virtually indistinguishable from ovarian dysgerminoma. Case presentation: We report the case of a 37-year-old multiparous woman (G3P3) who presented on the fourth postpartum day with progressive abdominal distension and discomfort. Detailed clinical examination and imaging pointed toward an adnexal mass, likely right ovarian dysgerminoma. Tumor markers, including CA-125 (cancer antigen 125) and β-hCG (beta-human chorionic gonadotropin), were elevated. A staging laparotomy was planned based on the presumptive diagnosis of ovarian malignancy, which revealed a large fundal uterine fibroid undergoing red degeneration. The patient underwent a total abdominal hysterectomy. Clinical discussion: The presence of an adnexal or pelvic mass in the postpartum period presents diagnostic complexity. Red degeneration is a hemorrhagic infarction of a uterine fibroid. The definite diagnosis is often confirmed by laparotomy and histologic confirmation. Tumor markers may be falsely elevated in postpartum women or in association with benign gynecological conditions. Red degeneration should be part of the differential diagnosis when a postpartum woman presents with an abdominopelvic mass, especially if she has a known fibroid. Conclusion: This case underscores the importance of integrating clinical, biochemical, and radiologic data in the diagnosis of uterine fibroids – while remaining open to alternate benign diagnoses at the same time – to avoid overtreatment or delayed appropriate management.
- Open Access
- 4 September 2025
- Published by Wiley
A Rare Case Report of 46XX Pure Gonadal Dysgenesis with Yolk Sac Tumor: Diagnostic Challenges and Management
- 4 September 2025
- Published by Wiley
Open AccessA Rare Case Report of 46XX Pure Gonadal Dysgenesis with Yolk Sac Tumor: Diagnostic Challenges and Management
- Open Access
- 18 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (9) , 6121-6126
Hypertriglyceridemia induced acute pancreatitis in pregnancy: a case report
Introduction and importance: various metabolic and physiologic changes that occur during pregnancy, can sometimes lead to severe hypertriglyceridemia during pregnancy. The resultant hypertriglyceridemia may lead to acute pancreatitis in pregnancy which even being rare poses significant health risks to both the child and the mother. Presentation of case: A 26-year-old female G4P1L1A2 at 36+3 weeks of gestation presented with an acute onset of abdominal pain in the epigastric region and multiple episodes of vomiting. With diagnosis of Acute Pancreatitis, she was admitted in the ICU for the multidisciplinary approach with a plan to reduce the triglyceride levels rapidly. The woman was finally discharged against medical advice with oral antibiotics. Case discussion: Hypertriglyceridemia induced acute pancreatitis in a pregnancy is a rare occurrence, usually seen in females with prior hyperlipidemia and with genetic predisposition which is associated with significant morbidity and mortality. Our patient presented with TG levels above 1500 mg/dl. The favoured treatment modality in our case was insulin therapy and omega-3 fatty acids. Baby was delivered through an elective caesarean section. Conclusion: Proper treatment modality according to the TG levels of the patient, along with proper continuous proper monitoring of both the mother and the baby is very much essential. Injectable insulin and diet modification are equally important. The mode of delivery is assessed based on various parameters of fetal maturity and maternal risk factors.
- 18 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (9) , 6121-6126
Open AccessHypertriglyceridemia induced acute pancreatitis in pregnancy: a case report
Introduction and importance: various metabolic and physiologic changes that occur during pregnancy, can sometimes lead to severe hypertriglyceridemia during pregnancy. The resultant hypertriglyceridemia may lead to acute pancreatitis in pregnancy which even being rare poses significant health risks to both the child and the mother. Presentation of case: A 26-year-old female G4P1L1A2 at 36+3 weeks of gestation presented with an acute onset of abdominal pain in the epigastric region and multiple episodes of vomiting. With diagnosis of Acute Pancreatitis, she was admitted in the ICU for the multidisciplinary approach with a plan to reduce the triglyceride levels rapidly. The woman was finally discharged against medical advice with oral antibiotics. Case discussion: Hypertriglyceridemia induced acute pancreatitis in a pregnancy is a rare occurrence, usually seen in females with prior hyperlipidemia and with genetic predisposition which is associated with significant morbidity and mortality. Our patient presented with TG levels above 1500 mg/dl. The favoured treatment modality in our case was insulin therapy and omega-3 fatty acids. Baby was delivered through an elective caesarean section. Conclusion: Proper treatment modality according to the TG levels of the patient, along with proper continuous proper monitoring of both the mother and the baby is very much essential. Injectable insulin and diet modification are equally important. The mode of delivery is assessed based on various parameters of fetal maturity and maternal risk factors.